annual SGA:
$557.87M+$76.00M(+15.77%)Summary
- As of today (July 27, 2025), SRPT annual SGA is $557.87 million, with the most recent change of +$76.00 million (+15.77%) on December 31, 2024.
- During the last 3 years, SRPT annual SGA has risen by +$275.21 million (+97.37%).
- SRPT annual SGA is now at all-time high.
Performance
SRPT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$133.63M-$30.24M(-18.46%)Summary
- As of today (July 27, 2025), SRPT quarterly SGA is $133.63 million, with the most recent change of -$30.24 million (-18.46%) on March 1, 2025.
- Over the past year, SRPT quarterly SGA has increased by +$6.63 million (+5.22%).
- SRPT quarterly SGA is now -18.46% below its all-time high of $163.87 million, reached on December 31, 2024.
Performance
SRPT quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$17.64B-$248.39M(-1.43%)Summary
- As of today (July 27, 2025), SRPT TTM SGA is -$17.64 billion, with the most recent change of -$248.39 million (-1.43%) on March 1, 2025.
- Over the past year, SRPT TTM SGA has dropped by -$18.14 billion (-3641.66%).
- SRPT TTM SGA is now -135616.25% below its all-time high of -$13.00 million.
Performance
SRPT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SRPT Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.8% | +5.2% | -3641.7% |
| 3 y3 years | +97.4% | +86.0% | -6326.2% |
| 5 y5 years | +95.9% | +61.5% | -5731.2% |
SRPT Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.4% | -18.5% | +27.5% | -34.2% | +1.0% |
| 5 y | 5-year | at high | +97.4% | -18.5% | +118.6% | -93.3% | +1.0% |
| alltime | all time | at high | >+9999.0% | -18.5% | >+9999.0% | <-9999.0% | +1.0% |
SRPT Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $133.63M(-18.5%) | $564.50M(+1.2%) |
| Dec 2024 | $557.87M(+15.8%) | $163.87M(+27.8%) | $557.87M(+6.1%) |
| Sep 2024 | - | $128.20M(-7.6%) | $525.70M(+1.4%) |
| Jun 2024 | - | $138.80M(+9.3%) | $518.39M(+4.1%) |
| Mar 2024 | - | $127.00M(-3.6%) | $498.16M(+3.4%) |
| Dec 2023 | $481.87M(+6.7%) | $131.70M(+8.9%) | $481.87M(+2.4%) |
| Sep 2023 | - | $120.89M(+2.0%) | $470.65M(+3.5%) |
| Jun 2023 | - | $118.56M(+7.1%) | $454.54M(-7.3%) |
| Mar 2023 | - | $110.71M(-8.1%) | $490.30M(+8.6%) |
| Dec 2022 | $451.42M(+59.7%) | $120.48M(+15.0%) | $451.42M(+10.4%) |
| Sep 2022 | - | $104.79M(-32.1%) | $409.00M(+12.0%) |
| Jun 2022 | - | $154.32M(+114.8%) | $365.34M(+28.9%) |
| Mar 2022 | - | $71.84M(-8.0%) | $283.37M(+0.3%) |
| Dec 2021 | $282.66M(-11.1%) | $78.06M(+27.7%) | $282.66M(-2.7%) |
| Sep 2021 | - | $61.13M(-15.5%) | $290.65M(-4.7%) |
| Jun 2021 | - | $72.35M(+1.7%) | $304.90M(-0.4%) |
| Mar 2021 | - | $71.13M(-17.3%) | $306.24M(-3.7%) |
| Dec 2020 | $317.88M(+11.6%) | $86.05M(+14.2%) | $317.88M(+1.5%) |
| Sep 2020 | - | $75.37M(+2.3%) | $313.25M(-0.0%) |
| Jun 2020 | - | $73.69M(-11.0%) | $313.31M(+2.1%) |
| Mar 2020 | - | $82.77M(+1.7%) | $307.01M(+7.8%) |
| Dec 2019 | $284.81M(+37.1%) | $81.42M(+7.9%) | $284.81M(+7.3%) |
| Sep 2019 | - | $75.43M(+11.9%) | $265.39M(+9.2%) |
| Jun 2019 | - | $67.39M(+11.3%) | $243.00M(+8.0%) |
| Mar 2019 | - | $60.57M(-2.3%) | $224.99M(+8.3%) |
| Dec 2018 | $207.76M(+69.3%) | $62.00M(+16.9%) | $207.76M(+15.1%) |
| Sep 2018 | - | $53.04M(+7.4%) | $180.57M(+16.0%) |
| Jun 2018 | - | $49.38M(+13.9%) | $155.71M(+11.2%) |
| Mar 2018 | - | $43.34M(+24.5%) | $139.98M(+13.9%) |
| Dec 2017 | $122.68M(+51.1%) | $34.81M(+23.5%) | $122.85M(+12.6%) |
| Sep 2017 | - | $28.18M(-16.3%) | $109.07M(+5.8%) |
| Jun 2017 | - | $33.65M(+28.4%) | $103.08M(+18.4%) |
| Mar 2017 | - | $26.22M(+24.7%) | $87.06M(+6.5%) |
| Dec 2016 | $81.20M(+8.2%) | $21.03M(-5.2%) | $81.72M(-3.9%) |
| Sep 2016 | - | $22.18M(+25.8%) | $85.03M(+9.1%) |
| Jun 2016 | - | $17.64M(-15.5%) | $77.93M(+6.4%) |
| Mar 2016 | - | $20.88M(-14.2%) | $73.22M(-2.4%) |
| Dec 2015 | $75.04M(+52.2%) | $24.33M(+61.2%) | $75.04M(+16.1%) |
| Sep 2015 | - | $15.09M(+16.7%) | $64.63M(+3.5%) |
| Jun 2015 | - | $12.93M(-43.0%) | $62.42M(+1.2%) |
| Mar 2015 | - | $22.70M(+63.1%) | $61.71M(+25.1%) |
| Dec 2014 | $49.31M(+56.1%) | $13.92M(+8.0%) | $49.31M(+7.7%) |
| Sep 2014 | - | $12.88M(+5.5%) | $45.80M(+11.9%) |
| Jun 2014 | - | $12.21M(+18.5%) | $40.93M(+14.4%) |
| Mar 2014 | - | $10.30M(-0.9%) | $35.77M(+13.2%) |
| Dec 2013 | $31.59M(+116.0%) | $10.40M(+29.8%) | $31.59M(+21.2%) |
| Sep 2013 | - | $8.01M(+13.6%) | $26.06M(+20.6%) |
| Jun 2013 | - | $7.05M(+15.1%) | $21.61M(+23.7%) |
| Mar 2013 | - | $6.13M(+25.8%) | $17.48M(+19.5%) |
| Dec 2012 | $14.63M(-8.9%) | $4.87M(+36.6%) | $14.63M(+7.2%) |
| Sep 2012 | - | $3.56M(+22.3%) | $13.64M(+2.9%) |
| Jun 2012 | - | $2.92M(-11.2%) | $13.27M(-7.3%) |
| Mar 2012 | - | $3.28M(-15.5%) | $14.31M(-10.9%) |
| Dec 2011 | $16.05M(+11.6%) | $3.88M(+21.9%) | $16.05M(+3.3%) |
| Sep 2011 | - | $3.19M(-19.6%) | $15.54M(-1.6%) |
| Jun 2011 | - | $3.96M(-21.2%) | $15.79M(-4.7%) |
| Mar 2011 | - | $5.03M(+49.4%) | $16.56M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $14.38M(+65.4%) | $3.37M(-2.2%) | $14.38M(+6.6%) |
| Sep 2010 | - | $3.44M(-27.3%) | $13.49M(+13.8%) |
| Jun 2010 | - | $4.73M(+66.4%) | $11.85M(+27.1%) |
| Mar 2010 | - | $2.84M(+15.1%) | $9.32M(+7.2%) |
| Dec 2009 | $8.70M(-24.2%) | $2.47M(+37.2%) | $8.70M(-19.8%) |
| Sep 2009 | - | $1.80M(-18.4%) | $10.84M(-11.2%) |
| Jun 2009 | - | $2.21M(-0.6%) | $12.22M(+0.2%) |
| Mar 2009 | - | $2.22M(-51.9%) | $12.19M(-2.7%) |
| Dec 2008 | $11.47M(+22.9%) | $4.62M(+45.4%) | $12.53M(+33.8%) |
| Sep 2008 | - | $3.17M(+45.3%) | $9.36M(+21.1%) |
| Jun 2008 | - | $2.18M(-14.5%) | $7.73M(+2.0%) |
| Mar 2008 | - | $2.55M(+75.7%) | $7.58M(-18.8%) |
| Dec 2007 | $9.33M(+20.4%) | $1.45M(-5.9%) | $9.33M(-6.2%) |
| Sep 2007 | - | $1.54M(-23.9%) | $9.95M(+2.0%) |
| Jun 2007 | - | $2.03M(-52.8%) | $9.75M(+5.6%) |
| Mar 2007 | - | $4.30M(+108.1%) | $9.23M(+19.1%) |
| Dec 2006 | $7.75M(+49.6%) | $2.07M(+53.5%) | $7.75M(+9.3%) |
| Sep 2006 | - | $1.35M(-11.1%) | $7.09M(+4.3%) |
| Jun 2006 | - | $1.52M(-46.3%) | $6.80M(+3.7%) |
| Mar 2006 | - | $2.82M(+100.2%) | $6.56M(+26.5%) |
| Dec 2005 | $5.18M(+9.4%) | $1.41M(+33.9%) | $5.18M(-0.1%) |
| Sep 2005 | - | $1.05M(-17.3%) | $5.19M(+1.7%) |
| Jun 2005 | - | $1.27M(-12.2%) | $5.10M(+3.2%) |
| Mar 2005 | - | $1.45M(+2.2%) | $4.95M(+4.4%) |
| Dec 2004 | $4.74M(+3.9%) | $1.42M(+46.9%) | $4.74M(+12.6%) |
| Sep 2004 | - | $964.70K(-13.6%) | $4.21M(-12.4%) |
| Jun 2004 | - | $1.12M(-9.9%) | $4.80M(-1.3%) |
| Mar 2004 | - | $1.24M(+39.4%) | $4.86M(+6.7%) |
| Dec 2003 | $4.56M(+21.1%) | $888.40K(-43.1%) | $4.56M(+2.6%) |
| Sep 2003 | - | $1.56M(+32.5%) | $4.44M(+14.1%) |
| Jun 2003 | - | $1.18M(+26.1%) | $3.89M(+7.8%) |
| Mar 2003 | - | $933.40K(+20.5%) | $3.61M(-4.0%) |
| Dec 2002 | $3.76M(+12.1%) | $774.40K(-23.3%) | $3.76M(-0.8%) |
| Sep 2002 | - | $1.01M(+12.7%) | $3.80M(+3.6%) |
| Jun 2002 | - | $895.70K(-17.4%) | $3.66M(+5.4%) |
| Mar 2002 | - | $1.08M(+34.5%) | $3.48M(+3.6%) |
| Dec 2001 | $3.36M(+47.9%) | $806.50K(-8.1%) | $3.36M(+0.6%) |
| Sep 2001 | - | $877.60K(+23.7%) | $3.34M(+10.6%) |
| Jun 2001 | - | $709.50K(-26.4%) | $3.02M(+7.8%) |
| Mar 2001 | - | $964.10K(+22.6%) | $2.80M(+23.3%) |
| Dec 2000 | $2.27M(+33.5%) | $786.10K(+40.9%) | $2.27M(+20.5%) |
| Sep 2000 | - | $557.90K(+13.8%) | $1.88M(+3.2%) |
| Jun 2000 | - | $490.20K(+12.4%) | $1.83M(+5.2%) |
| Mar 2000 | - | $436.10K(+9.0%) | $1.74M(+2.1%) |
| Dec 1999 | $1.70M(+6.3%) | $400.00K(-20.0%) | $1.70M(0.0%) |
| Sep 1999 | - | $500.00K(+25.0%) | $1.70M(+6.3%) |
| Jun 1999 | - | $400.00K(0.0%) | $1.60M(-5.9%) |
| Mar 1999 | - | $400.00K(0.0%) | $1.70M(+6.3%) |
| Dec 1998 | $1.60M(+23.1%) | $400.00K(0.0%) | $1.60M(0.0%) |
| Sep 1998 | - | $400.00K(-20.0%) | $1.60M(+6.7%) |
| Jun 1998 | - | $500.00K(+66.7%) | $1.50M(+7.1%) |
| Mar 1998 | - | $300.00K(-25.0%) | $1.40M(+7.7%) |
| Dec 1997 | $1.30M(+116.7%) | $400.00K(+33.3%) | $1.30M(+44.4%) |
| Sep 1997 | - | $300.00K(-25.0%) | $900.00K(+50.0%) |
| Jun 1997 | - | $400.00K(+100.0%) | $600.00K(+200.0%) |
| Mar 1997 | - | $200.00K | $200.00K |
| Dec 1996 | $600.00K | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual SGA year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM SGA year-on-year change?
What is Sarepta Therapeutics, Inc. annual SGA?
The current annual SGA of SRPT is $557.87M
What is the all time high annual SGA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual SGA is $557.87M
What is Sarepta Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, SRPT annual SGA has changed by +$76.00M (+15.77%)
What is Sarepta Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of SRPT is $133.63M
What is the all time high quarterly SGA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly SGA is $163.87M
What is Sarepta Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, SRPT quarterly SGA has changed by +$6.63M (+5.22%)
What is Sarepta Therapeutics, Inc. TTM SGA?
The current TTM SGA of SRPT is -$17.64B
What is the all time high TTM SGA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM SGA is -$13.00M
What is Sarepta Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, SRPT TTM SGA has changed by -$18.14B (-3641.66%)